Provided by Tiger Trade Technology Pte. Ltd.

IMMUNOTECH-B

2.490
-0.050-1.97%
Volume:379.52K
Turnover:934.27K
Market Cap:1.54B
PE:-6.86
High:2.560
Open:2.560
Low:2.390
Close:2.540
52wk High:5.830
52wk Low:2.300
Shares:618.00M
HK Float Shares:618.00M
Volume Ratio:2.87
T/O Rate:0.06%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.363
ROE:-242.61%
ROA:-18.75%
PB:-97.12
PE(LYR):-6.86
PS:- -

Loading ...

Stock Track | Immunotech Biopharm Plummets 5.51% Intraday on Widening 2025 Losses

Stock Track
·
Yesterday

Immunotech Biopharm's 2025 Loss Widens

MT Newswires Live
·
Yesterday

Biokin Pharmaceutical's Innovative Drug BL-ARC002 Injection Receives Clinical Trial Authorization

Stock News
·
Mar 22

Overcoming the Final Hurdle: How Commercial Health Insurance Supports Innovative Drugs

Deep News
·
Mar 21

IMMUNOTECH-B Revises Remuneration Committee Mandate, Enhancing Oversight on Director and Executive Pay

Bulletin Express
·
Mar 20

BRIEF-Immunotech Biopharm Posts Loss And Total Comprehensive Expense For Year Attributable Rmb230.8 Million

Reuters
·
Mar 20

IMMUNOTECH-B Reports Annual Results: Shareholder Loss Widens to 231 Million Yuan

Stock News
·
Mar 20

Immunotech-B Revises Audit Committee Charter to Enhance Financial Oversight

Bulletin Express
·
Mar 20

Immunotech Biopharm FY2025 loss before tax rises 23.9% to RMB230.91 million as other losses, net widen to RMB69.54 million

Reuters
·
Mar 20

Immunotech Biopharm - Loss and Total Comprehensive Expense for Year Attributable RMB230.8 Mln

THOMSON REUTERS
·
Mar 20

China Galaxy Securities Bullish on 2026 Healthcare Investment Opportunities, Recommends Innovative Drugs, Devices, and Medical AI

Stock News
·
Mar 20

Innovative Drug Stocks Retreat After Early Gains, Institutions Signal Bottoming Signs

Deep News
·
Mar 20

Innovative Drug Multi-tier Payment System Continues to Improve, Domestic Products Gain Global Competitiveness

Stock News
·
Mar 19

Biopharmaceutical Stocks Experience Downturn, Kexing Biopharm Leads Declines with Over 10% Drop

Deep News
·
Mar 19

Innovative Drug Leaders Show Strong Activity, Huabao Fund's HK Connect Innovative Drug ETF (520880) Reclaims 20-Day Moving Average

Deep News
·
Mar 18

New ETF Launches to Tap Hong Kong Biotech Revival: Huatai-PineBridge's Hang Seng Biotech ETF (513930)

Deep News
·
Mar 18

Zhengda Tianqing's Xie Chengrun: Global Recognition Grows for Domestic Innovative Drugs, U.S. Multinational Pharma Firms Flock to China for Acquisitions

Deep News
·
Mar 17

Healthcare Sector Shows Resilience Amid Volatile Session

Deep News
·
Mar 17

From R&D Accumulation to Value Realization: Innovative Drugs May Enter a New Cycle

Deep News
·
Mar 17

Monkey King Biotech Plummets as Major Shareholders Liquidate Entire Stakes

Deep News
·
Mar 17